Endometrial Cancer
📧 Sign up to get email alerts when something new happens for Endometrial Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-02-06Clinical Trial Update: A Study of Durvalumab With or Without Tremelimumab in Endometrial Cancer [Phase 2]
Phase 2 study evaluating durvalumab with or without tremelimumab in endometrial cancer and carcinosarcoma has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2024-01-30Clinical Trial Update: Study of Niraparib and TSR-042 in Recurrent Endometrial Cancer [Phase 2]
Phase 2 clinical trial investigating niraparib in combination with TSR-042 for recurrent endometrial cancer.
-
CLINICAL_TRIALS trial_result · 2024-01-11Clinical Trial Update: Dendritic Cells for Immunotherapy of Metastatic Endometrial Cancer Patients [Phase 2]
Phase 2 clinical trial update on dendritic cell-based immunotherapy for metastatic endometrial cancer has completed.
-
CLINICAL_TRIALS trial_result · 2024-01-05Clinical Trial Update: Comparison of Nodal Staging in Endometrial Cancer [Phase 3]
Phase 3 clinical trial investigating nodal staging in endometrial cancer has been terminated.
-
CLINICAL_TRIALS trial_result · 2023-12-18Clinical Trial Update: Adjuvant Sequential & Concurrent CarboTaxol + Radiotherapy for High Risk Endometrial Cancer [Phase 2]
Phase 2 clinical trial update evaluating adjuvant sequential and concurrent Carboplatin-Taxol with radiotherapy for high-risk endometrial ca…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2023-12-07Clinical Trial Update: A Phase 1/2 Study of INCB001158 in Combination With Chemotherapy in Subjects With Solid Tumors [Phase 1, Phase 2]
Results from a Phase 1/2 study of INCB001158 in combination with chemotherapy for solid tumors, including biliary tract cancer and colorecta…
-
CLINICAL_TRIALS trial_result · 2023-12-01Clinical Trial Update: Feasibility of Gallium-68-tilmanocept PET/CT for Sentinel Lymph Node Detection in Endometrial Cancer [Phase 3]
Phase 3 trial assessing feasibility of Gallium-68-tilmanocept PET/CT for sentinel lymph node detection in endometrial cancer.
-
CLINICAL_TRIALS trial_result · 2023-11-28Clinical Trial Update: Health and Recovery Program in Increasing Physical Activity Level in Stage IA-IIIA Endometrial Cancer Survivors [Phase 2]
A Phase 2 clinical trial evaluated a Health and Recovery Program aimed at increasing physical activity levels in endometrial cancer survivor…
-
CLINICAL_TRIALS trial_result · 2023-11-13Clinical Trial Update: Carboplatin, Paclitaxel With or Without Avelumab in Advanced or Recurrent Endometrial Cancer [Phase 2]
Phase 2 trial evaluating carboplatin and paclitaxel with or without avelumab in advanced or recurrent endometrial cancer. Status is UNKNOWN.
-
CLINICAL_TRIALS trial_result · 2023-10-26Clinical Trial Update: Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With High-Risk Endometrial Cancer [Phase 2]
A Phase 2 clinical trial investigating radiation therapy with Paclitaxel and Carboplatin in high-risk endometrial cancer was terminated; res…
-
CLINICAL_TRIALS trial_result · 2023-10-11Clinical Trial Update: PORTEC-4a: Molecular Profile-based Versus Standard Adjuvant Radiotherapy in Endometrial Cancer [Phase 3]
Phase 3 trial evaluating molecular profile-based versus standard adjuvant radiotherapy in endometrial cancer; currently ACTIVE_NOT_RECRUITIN…
-
CLINICAL_TRIALS trial_result · 2023-10-11Clinical Trial Update: Concurrent Use Lymphoseek & Indocyanine Green in Sentinel Lymph Node Detection in Endometrial Cancer [Phase 2]
Phase 2 trial investigating concurrent use of Lymphoseek and Indocyanine Green for sentinel lymph node detection in endometrial cancer; stud…
-
CLINICAL_TRIALS trial_result · 2023-10-11Clinical Trial Update: Randomized Trial of Radiation Therapy With or Without Chemotherapy for Endometrial Cancer [Phase 3]
A randomized Phase 3 trial evaluating radiation therapy with or without chemotherapy for endometrial cancer is in an unknown status.
-
CLINICAL_TRIALS trial_result · 2023-10-04Clinical Trial Update: TORC1/2 Inhibitor MLN0128 and Bevacizumab in Treating Patients With Recurrent Glioblastoma or Advanced Solid Tumors [Phase 1]
Phase 1 results for a study combining the TORC1/2 inhibitor MLN0128 (sapanisertib) with bevacizumab in adults with recurrent glioblastoma or…
-
CLINICAL_TRIALS trial_result · 2023-09-18Clinical Trial Update: Sentinel Node in Endometrial Cancer [Phase 2]
Phase 2 clinical trial update investigating sentinel node mapping in endometrial cancer.
-
CLINICAL_TRIALS trial_result · 2023-09-06Clinical Trial Update: GINECO-EN102b - BKM120 as Monotherapy in the Treatment of Initial or Recurrent Metastatic Endometrial Cancer [Phase 2]
Phase 2 trial update of BKM120 as monotherapy for initial or recurrent metastatic endometrial cancer has completed.
-
CLINICAL_TRIALS trial_result · 2023-08-04Clinical Trial Update: Perifosine in Treating Patients With Metastatic or Locally Advanced Soft Tissue Sarcoma [Phase 2]
A Phase 2 clinical trial evaluating perifosine for metastatic or locally advanced soft tissue sarcoma has completed enrollment.
-
CLINICAL_TRIALS trial_result · 2023-08-04Clinical Trial Update: Ridaforolimus in Treating Patients With Recurrent Metastatic and/or Locally Advanced Endometrial Cancer [Phase 2]
Phase 2 clinical trial update for ridaforolimus in recurrent/metastatic and locally advanced endometrial cancer completes enrollment.
-
CLINICAL_TRIALS trial_result · 2023-06-09Clinical Trial Update: A Study of DKN-01 as a Monotherapy or in Combination With Paclitaxel in Patients With Recurrent Epithelial Endometrial or Epithelial Ovarian Cancer or Carcinosarcoma [Phase 2]
Phase 2 study of DKN-01 as a monotherapy or with paclitaxel in recurrent epithelial endometrial cancer, epithelial ovarian cancer, or carcin…
-
CLINICAL_TRIALS trial_result · 2023-06-01Clinical Trial Update: Risk Factors of Immune-ChEckpoint Inhibitors MEdiated Liver, Gastrointestinal, Endocrine and Skin Toxicity [Phase 1, Phase 2]
Clinical trial exploring risk factors of immune checkpoint inhibitor–mediated liver, GI, endocrine, and skin toxicity across early-phase tri…
-
CLINICAL_TRIALS trial_result · 2023-04-18Clinical Trial Update: Evaluation of Carboplatin/Paclitaxel With and Without Trastuzumab (Herceptin) in Uterine Serous Cancer [Phase 2]
Phase 2 trial evaluating carboplatin/paclitaxel with or without trastuzumab in uterine serous/endometrial cancer completed; results posted i…
-
CLINICAL_TRIALS trial_result · 2023-04-13Clinical Trial Update: Clinical Effects of Metformin on Fertility-sparing Treatment for Early Endometrial Cancer [Phase 3]
A Phase 3 clinical trial evaluating metformin's effects on fertility-sparing treatment for early endometrial cancer.
-
CLINICAL_TRIALS trial_result · 2023-04-12Clinical Trial Update: NR in Chemo-induced Peripheral Neuropathy [Phase 2]
Phase 2 trial update for NR in chemo-induced peripheral neuropathy shows termination with posted results.
-
CLINICAL_TRIALS trial_result · 2023-03-29Clinical Trial Update: Radiation Therapy With or Without Cisplatin in Treating Patients With Recurrent Endometrial Cancer [Phase 2]
Phase 2 trial evaluating radiation therapy with or without cisplatin for recurrent endometrial cancer.
-
CLINICAL_TRIALS trial_result · 2023-02-22Clinical Trial Update: A Study to Assess the Efficacy and Safety of ABTL0812 [Phase 1, Phase 2]
Phase 1/2 trial evaluating ABTL0812 for endometrial cancer and squamous non-small cell lung cancer has completed.